Charles River Laboratories (CRL) Tops Q1 EPS by 8c; Boosts FY16 EPS Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. TSLA
7. DPZ
8. NVDA
9. PRIM
10. META

Go back to Charles River Laboratories (CRL) Tops Q1 EPS by 8c; Boosts FY16 EPS Outlook

Charles River Laboratories (CRL) PT Increases to $83 - UBS

May 5, 2016 9:00 AM EDT

UBS analyst, Jonathan Groberg, raised his PT on Charles River Labs (NYSE: CRL) to $83 from $76 but maintained his Neutral rating after 1Q16 beats and management raises full year EPS guidance. Revenue of $355m was in-line with consensus estimates and EPS of $0.98 was above consensus estimates... More